ID

21760

Description

A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00413036

Link

https://clinicaltrials.gov/show/NCT00413036

Keywords

  1. 4/28/17 4/28/17 -
Uploaded on

April 28, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma, Non-Hodgkin's NCT00413036

Eligibility Lymphoma, Non-Hodgkin's NCT00413036

Criteria
Description

Criteria

biopsy proven aggressive non-hodgkin's lymphoma
Description

Aggressive Non-Hodgkin Lymphoma Biopsy

Data type

boolean

Alias
UMLS CUI [1,1]
C1332225
UMLS CUI [1,2]
C0005558
follicular center lymphoma grade 3.
Description

Follicular Lymphoma Ann Arbor lymphoma staging system

Data type

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0432516
diffuse large b-cell lymphoma.
Description

Diffuse Large B-Cell Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0079744
mantle cell lymphoma.
Description

mantle cell lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0334634
transformed lymphoma.
Description

Lymphoma Transformed

Data type

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0457344
relapsed or refractory to previous therapy for lymphoma
Description

Therapeutic procedure Lymphoma Relapse | Therapeutic procedure Lymphoma refractory

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0024299
UMLS CUI [1,3]
C0277556
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0024299
UMLS CUI [2,3]
C0205269
at least one prior combination chemotherapy regime
Description

Combination Chemotherapy Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1521750
UMLS CUI [1,2]
C1265611
measurable disease on cross sectional imaging that is at least 2 cm in the longest diameter
Description

Measurable Disease Diameter Cross-sectional imaging

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1301886
UMLS CUI [1,3]
C3824793
eastern cooperative oncology group (ecog) performance score of 0, 1 or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
willing to follow the pregnancy precautions
Description

Contraceptive methods Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
key exclusion criteria
Description

Exclusion Criteria Main

Data type

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
any of the following laboratory abnormalities.
Description

LABORATORY ABNORMALITIES

Data type

boolean

Alias
UMLS CUI [1]
C1853129
absolute neutrophil count (anc) < 1,500 cells/mm^3 (1.5*10^9/l).
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelet count < 60,000/mm^3 (60*10^9/l).
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
calculated creatinine clearance of <50ml/min
Description

Estimation of creatinine clearance by Cockcroft-Gault formula

Data type

boolean

Alias
UMLS CUI [1]
C2711451
serum glutamic oxaloacetic transaminase/aspartate aminotransferase (sgot/ast) or serum glutamic pyruvic transaminase/alanine transaminase (sgpt/alt) 5.0 times upper limit of normal (uln).
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
serum total bilirubin > 2.0 mg/dl (34 µmol/l)/conjugated bilirubin >0.8mg/dl.
Description

Serum total bilirubin measurement | Conjugated bilirubin level

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0428439
subjects who are candidates for and willing to undergo an autologous stem cell transplant.
Description

Autologous hematopoietic stem cell transplant Receive Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C2193200
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C0600109
history of active central nervous system (cns) lymphoma within the previous 6 months
Description

Central nervous system lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0742472
history of other malignancies within the past year
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
positive human immunodeficiency virus (hiv) or active hepatitis b or c
Description

HIV Seropositivity | Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196

Similar models

Eligibility Lymphoma, Non-Hodgkin's NCT00413036

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Aggressive Non-Hodgkin Lymphoma Biopsy
Item
biopsy proven aggressive non-hodgkin's lymphoma
boolean
C1332225 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Follicular Lymphoma Ann Arbor lymphoma staging system
Item
follicular center lymphoma grade 3.
boolean
C0024301 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
Diffuse Large B-Cell Lymphoma
Item
diffuse large b-cell lymphoma.
boolean
C0079744 (UMLS CUI [1])
mantle cell lymphoma
Item
mantle cell lymphoma.
boolean
C0334634 (UMLS CUI [1])
Lymphoma Transformed
Item
transformed lymphoma.
boolean
C0024299 (UMLS CUI [1,1])
C0457344 (UMLS CUI [1,2])
Therapeutic procedure Lymphoma Relapse | Therapeutic procedure Lymphoma refractory
Item
relapsed or refractory to previous therapy for lymphoma
boolean
C0087111 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
Combination Chemotherapy Quantity
Item
at least one prior combination chemotherapy regime
boolean
C1521750 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Measurable Disease Diameter Cross-sectional imaging
Item
measurable disease on cross sectional imaging that is at least 2 cm in the longest diameter
boolean
C1513041 (UMLS CUI [1,1])
C1301886 (UMLS CUI [1,2])
C3824793 (UMLS CUI [1,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance score of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods Willing
Item
willing to follow the pregnancy precautions
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Exclusion Criteria Main
Item
key exclusion criteria
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
LABORATORY ABNORMALITIES
Item
any of the following laboratory abnormalities.
boolean
C1853129 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count (anc) < 1,500 cells/mm^3 (1.5*10^9/l).
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count < 60,000/mm^3 (60*10^9/l).
boolean
C0032181 (UMLS CUI [1])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
calculated creatinine clearance of <50ml/min
boolean
C2711451 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
serum glutamic oxaloacetic transaminase/aspartate aminotransferase (sgot/ast) or serum glutamic pyruvic transaminase/alanine transaminase (sgpt/alt) 5.0 times upper limit of normal (uln).
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Serum total bilirubin measurement | Conjugated bilirubin level
Item
serum total bilirubin > 2.0 mg/dl (34 µmol/l)/conjugated bilirubin >0.8mg/dl.
boolean
C1278039 (UMLS CUI [1])
C0428439 (UMLS CUI [2])
Autologous hematopoietic stem cell transplant Receive Willing
Item
subjects who are candidates for and willing to undergo an autologous stem cell transplant.
boolean
C2193200 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
Central nervous system lymphoma
Item
history of active central nervous system (cns) lymphoma within the previous 6 months
boolean
C0742472 (UMLS CUI [1])
Malignant Neoplasms
Item
history of other malignancies within the past year
boolean
C0006826 (UMLS CUI [1])
HIV Seropositivity | Hepatitis B | Hepatitis C
Item
positive human immunodeficiency virus (hiv) or active hepatitis b or c
boolean
C0019699 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial